nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—CYP3A7—Progesterone—uterine cancer	0.137	0.248	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.137	0.248	CbGbCtD
Zaleplon—CYP3A5—Progesterone—uterine cancer	0.103	0.186	CbGbCtD
Zaleplon—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0604	0.109	CbGbCtD
Zaleplon—CYP3A5—Etoposide—uterine cancer	0.046	0.0831	CbGbCtD
Zaleplon—CYP3A4—Progesterone—uterine cancer	0.04	0.0724	CbGbCtD
Zaleplon—CYP3A4—Etoposide—uterine cancer	0.0179	0.0324	CbGbCtD
Zaleplon—CYP3A4—Doxorubicin—uterine cancer	0.0122	0.0221	CbGbCtD
Zaleplon—TSPO—oviduct—uterine cancer	0.0074	0.112	CbGeAlD
Zaleplon—TSPO—artery—uterine cancer	0.0049	0.074	CbGeAlD
Zaleplon—TSPO—exocrine gland—uterine cancer	0.00427	0.0645	CbGeAlD
Zaleplon—AOX1—myometrium—uterine cancer	0.00277	0.0419	CbGeAlD
Zaleplon—TSPO—myometrium—uterine cancer	0.00237	0.0358	CbGeAlD
Zaleplon—AOX1—uterine cervix—uterine cancer	0.00216	0.0326	CbGeAlD
Zaleplon—AOX1—decidua—uterine cancer	0.00206	0.031	CbGeAlD
Zaleplon—AOX1—renal system—uterine cancer	0.00202	0.0305	CbGeAlD
Zaleplon—AOX1—endometrium—uterine cancer	0.00195	0.0295	CbGeAlD
Zaleplon—AOX1—mammalian vulva—uterine cancer	0.00189	0.0285	CbGeAlD
Zaleplon—TSPO—epithelium—uterine cancer	0.00186	0.0281	CbGeAlD
Zaleplon—TSPO—uterine cervix—uterine cancer	0.00184	0.0278	CbGeAlD
Zaleplon—AOX1—uterus—uterine cancer	0.0018	0.0271	CbGeAlD
Zaleplon—TSPO—smooth muscle tissue—uterine cancer	0.00179	0.027	CbGeAlD
Zaleplon—TSPO—decidua—uterine cancer	0.00176	0.0265	CbGeAlD
Zaleplon—TSPO—renal system—uterine cancer	0.00172	0.026	CbGeAlD
Zaleplon—TSPO—endometrium—uterine cancer	0.00167	0.0252	CbGeAlD
Zaleplon—AOX1—female reproductive system—uterine cancer	0.00162	0.0244	CbGeAlD
Zaleplon—TSPO—mammalian vulva—uterine cancer	0.00161	0.0243	CbGeAlD
Zaleplon—TSPO—uterus—uterine cancer	0.00154	0.0232	CbGeAlD
Zaleplon—AOX1—female gonad—uterine cancer	0.00147	0.0222	CbGeAlD
Zaleplon—AOX1—vagina—uterine cancer	0.00146	0.0221	CbGeAlD
Zaleplon—TSPO—female reproductive system—uterine cancer	0.00138	0.0208	CbGeAlD
Zaleplon—GABRA2—vagina—uterine cancer	0.00135	0.0204	CbGeAlD
Zaleplon—TSPO—female gonad—uterine cancer	0.00126	0.019	CbGeAlD
Zaleplon—GABRB3—female reproductive system—uterine cancer	0.00125	0.0189	CbGeAlD
Zaleplon—TSPO—vagina—uterine cancer	0.00125	0.0189	CbGeAlD
Zaleplon—CYP3A5—uterine cervix—uterine cancer	0.00114	0.0172	CbGeAlD
Zaleplon—CYP3A5—renal system—uterine cancer	0.00107	0.0161	CbGeAlD
Zaleplon—AOX1—lymph node—uterine cancer	0.000946	0.0143	CbGeAlD
Zaleplon—GABRA2—lymph node—uterine cancer	0.000872	0.0132	CbGeAlD
Zaleplon—TSPO—lymph node—uterine cancer	0.000808	0.0122	CbGeAlD
Zaleplon—CYP3A4—renal system—uterine cancer	0.000801	0.0121	CbGeAlD
Zaleplon—CYP3A5—female gonad—uterine cancer	0.000778	0.0117	CbGeAlD
Zaleplon—CYP3A5—vagina—uterine cancer	0.000773	0.0117	CbGeAlD
Zaleplon—CYP3A4—female reproductive system—uterine cancer	0.000642	0.00969	CbGeAlD
Zaleplon—Eczema—Doxorubicin—uterine cancer	0.000299	0.000787	CcSEcCtD
Zaleplon—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000299	0.000785	CcSEcCtD
Zaleplon—Eye pain—Doxorubicin—uterine cancer	0.000298	0.000783	CcSEcCtD
Zaleplon—Hypoglycaemia—Epirubicin—uterine cancer	0.000298	0.000783	CcSEcCtD
Zaleplon—Nausea—Progesterone—uterine cancer	0.000296	0.000778	CcSEcCtD
Zaleplon—Diplopia—Epirubicin—uterine cancer	0.000291	0.000764	CcSEcCtD
Zaleplon—Osteoarthritis—Epirubicin—uterine cancer	0.000291	0.000764	CcSEcCtD
Zaleplon—Feeling abnormal—Dactinomycin—uterine cancer	0.00029	0.000763	CcSEcCtD
Zaleplon—Ill-defined disorder—Etoposide—uterine cancer	0.00029	0.000762	CcSEcCtD
Zaleplon—Anaemia—Etoposide—uterine cancer	0.000289	0.000759	CcSEcCtD
Zaleplon—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000288	0.000757	CcSEcCtD
Zaleplon—Increased appetite—Doxorubicin—uterine cancer	0.000286	0.000752	CcSEcCtD
Zaleplon—Affect lability—Epirubicin—uterine cancer	0.000286	0.000752	CcSEcCtD
Zaleplon—Migraine—Epirubicin—uterine cancer	0.000286	0.000752	CcSEcCtD
Zaleplon—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000285	0.000748	CcSEcCtD
Zaleplon—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000285	0.000747	CcSEcCtD
Zaleplon—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000283	0.000743	CcSEcCtD
Zaleplon—Malaise—Etoposide—uterine cancer	0.000282	0.00074	CcSEcCtD
Zaleplon—Dermatitis bullous—Doxorubicin—uterine cancer	0.000282	0.00074	CcSEcCtD
Zaleplon—Face oedema—Epirubicin—uterine cancer	0.000281	0.000738	CcSEcCtD
Zaleplon—Vertigo—Etoposide—uterine cancer	0.000281	0.000737	CcSEcCtD
Zaleplon—Purpura—Doxorubicin—uterine cancer	0.000279	0.000733	CcSEcCtD
Zaleplon—Abdominal pain—Dactinomycin—uterine cancer	0.000279	0.000732	CcSEcCtD
Zaleplon—Body temperature increased—Dactinomycin—uterine cancer	0.000279	0.000732	CcSEcCtD
Zaleplon—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000278	0.00073	CcSEcCtD
Zaleplon—Hypoglycaemia—Doxorubicin—uterine cancer	0.000276	0.000724	CcSEcCtD
Zaleplon—Mood swings—Epirubicin—uterine cancer	0.000276	0.000724	CcSEcCtD
Zaleplon—Loss of consciousness—Etoposide—uterine cancer	0.000275	0.000721	CcSEcCtD
Zaleplon—Ataxia—Epirubicin—uterine cancer	0.000273	0.000718	CcSEcCtD
Zaleplon—Hypertension—Etoposide—uterine cancer	0.00027	0.000709	CcSEcCtD
Zaleplon—Osteoarthritis—Doxorubicin—uterine cancer	0.000269	0.000707	CcSEcCtD
Zaleplon—Diplopia—Doxorubicin—uterine cancer	0.000269	0.000707	CcSEcCtD
Zaleplon—Liver function test abnormal—Epirubicin—uterine cancer	0.000269	0.000705	CcSEcCtD
Zaleplon—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000268	0.000705	CcSEcCtD
Zaleplon—Dry skin—Epirubicin—uterine cancer	0.000267	0.0007	CcSEcCtD
Zaleplon—Chest pain—Etoposide—uterine cancer	0.000266	0.000699	CcSEcCtD
Zaleplon—Orthostatic hypotension—Epirubicin—uterine cancer	0.000266	0.000698	CcSEcCtD
Zaleplon—Affect lability—Doxorubicin—uterine cancer	0.000265	0.000696	CcSEcCtD
Zaleplon—Migraine—Doxorubicin—uterine cancer	0.000265	0.000696	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000264	0.000694	CcSEcCtD
Zaleplon—Discomfort—Etoposide—uterine cancer	0.000263	0.00069	CcSEcCtD
Zaleplon—Breast disorder—Epirubicin—uterine cancer	0.000263	0.00069	CcSEcCtD
Zaleplon—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000262	0.000688	CcSEcCtD
Zaleplon—Face oedema—Doxorubicin—uterine cancer	0.00026	0.000682	CcSEcCtD
Zaleplon—Gastritis—Epirubicin—uterine cancer	0.000257	0.000676	CcSEcCtD
Zaleplon—Confusional state—Etoposide—uterine cancer	0.000257	0.000675	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000257	0.000674	CcSEcCtD
Zaleplon—Muscular weakness—Epirubicin—uterine cancer	0.000257	0.000674	CcSEcCtD
Zaleplon—Anaphylactic shock—Etoposide—uterine cancer	0.000255	0.00067	CcSEcCtD
Zaleplon—Mood swings—Doxorubicin—uterine cancer	0.000255	0.00067	CcSEcCtD
Zaleplon—Ataxia—Doxorubicin—uterine cancer	0.000253	0.000665	CcSEcCtD
Zaleplon—Asthenia—Dactinomycin—uterine cancer	0.000253	0.000664	CcSEcCtD
Zaleplon—Asthma—Epirubicin—uterine cancer	0.000251	0.00066	CcSEcCtD
Zaleplon—Dysphagia—Epirubicin—uterine cancer	0.000251	0.00066	CcSEcCtD
Zaleplon—Tachycardia—Etoposide—uterine cancer	0.000249	0.000654	CcSEcCtD
Zaleplon—Eosinophilia—Epirubicin—uterine cancer	0.000249	0.000654	CcSEcCtD
Zaleplon—Liver function test abnormal—Doxorubicin—uterine cancer	0.000248	0.000653	CcSEcCtD
Zaleplon—Skin disorder—Etoposide—uterine cancer	0.000248	0.000651	CcSEcCtD
Zaleplon—Dry skin—Doxorubicin—uterine cancer	0.000247	0.000648	CcSEcCtD
Zaleplon—Hyperhidrosis—Etoposide—uterine cancer	0.000247	0.000648	CcSEcCtD
Zaleplon—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000246	0.000646	CcSEcCtD
Zaleplon—Angina pectoris—Epirubicin—uterine cancer	0.000245	0.000643	CcSEcCtD
Zaleplon—Breast disorder—Doxorubicin—uterine cancer	0.000243	0.000639	CcSEcCtD
Zaleplon—Anorexia—Etoposide—uterine cancer	0.000243	0.000639	CcSEcCtD
Zaleplon—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000242	0.000637	CcSEcCtD
Zaleplon—Bronchitis—Epirubicin—uterine cancer	0.000242	0.000635	CcSEcCtD
Zaleplon—Hypotension—Etoposide—uterine cancer	0.000238	0.000626	CcSEcCtD
Zaleplon—Gastritis—Doxorubicin—uterine cancer	0.000238	0.000626	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000237	0.000623	CcSEcCtD
Zaleplon—Muscular weakness—Doxorubicin—uterine cancer	0.000237	0.000623	CcSEcCtD
Zaleplon—Dysuria—Epirubicin—uterine cancer	0.000235	0.000617	CcSEcCtD
Zaleplon—Asthma—Doxorubicin—uterine cancer	0.000233	0.000611	CcSEcCtD
Zaleplon—Dysphagia—Doxorubicin—uterine cancer	0.000233	0.000611	CcSEcCtD
Zaleplon—Pollakiuria—Epirubicin—uterine cancer	0.000232	0.00061	CcSEcCtD
Zaleplon—Eosinophilia—Doxorubicin—uterine cancer	0.00023	0.000605	CcSEcCtD
Zaleplon—Photosensitivity reaction—Epirubicin—uterine cancer	0.000229	0.000603	CcSEcCtD
Zaleplon—Paraesthesia—Etoposide—uterine cancer	0.000229	0.000602	CcSEcCtD
Zaleplon—Weight increased—Epirubicin—uterine cancer	0.000229	0.000601	CcSEcCtD
Zaleplon—Weight decreased—Epirubicin—uterine cancer	0.000227	0.000597	CcSEcCtD
Zaleplon—Dyspnoea—Etoposide—uterine cancer	0.000227	0.000597	CcSEcCtD
Zaleplon—Hyperglycaemia—Epirubicin—uterine cancer	0.000227	0.000596	CcSEcCtD
Zaleplon—Somnolence—Etoposide—uterine cancer	0.000227	0.000596	CcSEcCtD
Zaleplon—Angina pectoris—Doxorubicin—uterine cancer	0.000227	0.000595	CcSEcCtD
Zaleplon—Pneumonia—Epirubicin—uterine cancer	0.000225	0.000592	CcSEcCtD
Zaleplon—Bronchitis—Doxorubicin—uterine cancer	0.000224	0.000588	CcSEcCtD
Zaleplon—Rash—Dactinomycin—uterine cancer	0.000222	0.000584	CcSEcCtD
Zaleplon—Decreased appetite—Etoposide—uterine cancer	0.000222	0.000582	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Etoposide—uterine cancer	0.00022	0.000578	CcSEcCtD
Zaleplon—Neuropathy peripheral—Epirubicin—uterine cancer	0.00022	0.000577	CcSEcCtD
Zaleplon—Stomatitis—Epirubicin—uterine cancer	0.000218	0.000574	CcSEcCtD
Zaleplon—Pain—Etoposide—uterine cancer	0.000218	0.000573	CcSEcCtD
Zaleplon—Constipation—Etoposide—uterine cancer	0.000218	0.000573	CcSEcCtD
Zaleplon—Conjunctivitis—Epirubicin—uterine cancer	0.000218	0.000572	CcSEcCtD
Zaleplon—Dysuria—Doxorubicin—uterine cancer	0.000218	0.000571	CcSEcCtD
Zaleplon—Sweating—Epirubicin—uterine cancer	0.000215	0.000564	CcSEcCtD
Zaleplon—Pollakiuria—Doxorubicin—uterine cancer	0.000215	0.000564	CcSEcCtD
Zaleplon—Haematuria—Epirubicin—uterine cancer	0.000214	0.000561	CcSEcCtD
Zaleplon—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000212	0.000558	CcSEcCtD
Zaleplon—Hepatobiliary disease—Epirubicin—uterine cancer	0.000212	0.000557	CcSEcCtD
Zaleplon—Weight increased—Doxorubicin—uterine cancer	0.000212	0.000556	CcSEcCtD
Zaleplon—Epistaxis—Epirubicin—uterine cancer	0.000211	0.000555	CcSEcCtD
Zaleplon—Weight decreased—Doxorubicin—uterine cancer	0.00021	0.000553	CcSEcCtD
Zaleplon—Feeling abnormal—Etoposide—uterine cancer	0.00021	0.000552	CcSEcCtD
Zaleplon—Hyperglycaemia—Doxorubicin—uterine cancer	0.00021	0.000551	CcSEcCtD
Zaleplon—Nausea—Dactinomycin—uterine cancer	0.000209	0.00055	CcSEcCtD
Zaleplon—Pneumonia—Doxorubicin—uterine cancer	0.000209	0.000548	CcSEcCtD
Zaleplon—Gastrointestinal pain—Etoposide—uterine cancer	0.000209	0.000548	CcSEcCtD
Zaleplon—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000203	0.000534	CcSEcCtD
Zaleplon—Urticaria—Etoposide—uterine cancer	0.000203	0.000532	CcSEcCtD
Zaleplon—Stomatitis—Doxorubicin—uterine cancer	0.000202	0.000531	CcSEcCtD
Zaleplon—Body temperature increased—Etoposide—uterine cancer	0.000202	0.00053	CcSEcCtD
Zaleplon—Abdominal pain—Etoposide—uterine cancer	0.000202	0.00053	CcSEcCtD
Zaleplon—Conjunctivitis—Doxorubicin—uterine cancer	0.000202	0.00053	CcSEcCtD
Zaleplon—Hypoaesthesia—Epirubicin—uterine cancer	0.0002	0.000526	CcSEcCtD
Zaleplon—Sweating—Doxorubicin—uterine cancer	0.000199	0.000522	CcSEcCtD
Zaleplon—Oedema peripheral—Epirubicin—uterine cancer	0.000198	0.000521	CcSEcCtD
Zaleplon—Haematuria—Doxorubicin—uterine cancer	0.000198	0.000519	CcSEcCtD
Zaleplon—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000196	0.000515	CcSEcCtD
Zaleplon—Epistaxis—Doxorubicin—uterine cancer	0.000196	0.000514	CcSEcCtD
Zaleplon—Visual impairment—Epirubicin—uterine cancer	0.000194	0.000509	CcSEcCtD
Zaleplon—Eye disorder—Epirubicin—uterine cancer	0.000188	0.000494	CcSEcCtD
Zaleplon—Tinnitus—Epirubicin—uterine cancer	0.000188	0.000493	CcSEcCtD
Zaleplon—Hypoaesthesia—Doxorubicin—uterine cancer	0.000185	0.000487	CcSEcCtD
Zaleplon—Oedema peripheral—Doxorubicin—uterine cancer	0.000183	0.000482	CcSEcCtD
Zaleplon—Asthenia—Etoposide—uterine cancer	0.000183	0.000481	CcSEcCtD
Zaleplon—Immune system disorder—Epirubicin—uterine cancer	0.000182	0.000477	CcSEcCtD
Zaleplon—Chills—Epirubicin—uterine cancer	0.000181	0.000474	CcSEcCtD
Zaleplon—Pruritus—Etoposide—uterine cancer	0.00018	0.000474	CcSEcCtD
Zaleplon—Visual impairment—Doxorubicin—uterine cancer	0.000179	0.000471	CcSEcCtD
Zaleplon—Alopecia—Epirubicin—uterine cancer	0.000178	0.000467	CcSEcCtD
Zaleplon—Mental disorder—Epirubicin—uterine cancer	0.000176	0.000463	CcSEcCtD
Zaleplon—Malnutrition—Epirubicin—uterine cancer	0.000175	0.00046	CcSEcCtD
Zaleplon—Eye disorder—Doxorubicin—uterine cancer	0.000174	0.000457	CcSEcCtD
Zaleplon—Tinnitus—Doxorubicin—uterine cancer	0.000174	0.000456	CcSEcCtD
Zaleplon—Flatulence—Epirubicin—uterine cancer	0.000173	0.000453	CcSEcCtD
Zaleplon—Tension—Epirubicin—uterine cancer	0.000172	0.000451	CcSEcCtD
Zaleplon—Dysgeusia—Epirubicin—uterine cancer	0.000172	0.000451	CcSEcCtD
Zaleplon—Nervousness—Epirubicin—uterine cancer	0.00017	0.000447	CcSEcCtD
Zaleplon—Back pain—Epirubicin—uterine cancer	0.000169	0.000445	CcSEcCtD
Zaleplon—Dizziness—Etoposide—uterine cancer	0.000169	0.000443	CcSEcCtD
Zaleplon—Immune system disorder—Doxorubicin—uterine cancer	0.000168	0.000442	CcSEcCtD
Zaleplon—Chills—Doxorubicin—uterine cancer	0.000167	0.000439	CcSEcCtD
Zaleplon—Alopecia—Doxorubicin—uterine cancer	0.000165	0.000432	CcSEcCtD
Zaleplon—Mental disorder—Doxorubicin—uterine cancer	0.000163	0.000428	CcSEcCtD
Zaleplon—Ill-defined disorder—Epirubicin—uterine cancer	0.000163	0.000427	CcSEcCtD
Zaleplon—Malnutrition—Doxorubicin—uterine cancer	0.000162	0.000426	CcSEcCtD
Zaleplon—Anaemia—Epirubicin—uterine cancer	0.000162	0.000425	CcSEcCtD
Zaleplon—Agitation—Epirubicin—uterine cancer	0.000161	0.000423	CcSEcCtD
Zaleplon—Rash—Etoposide—uterine cancer	0.000161	0.000422	CcSEcCtD
Zaleplon—Dermatitis—Etoposide—uterine cancer	0.000161	0.000422	CcSEcCtD
Zaleplon—Headache—Etoposide—uterine cancer	0.00016	0.00042	CcSEcCtD
Zaleplon—Flatulence—Doxorubicin—uterine cancer	0.00016	0.000419	CcSEcCtD
Zaleplon—Tension—Doxorubicin—uterine cancer	0.000159	0.000418	CcSEcCtD
Zaleplon—Dysgeusia—Doxorubicin—uterine cancer	0.000159	0.000417	CcSEcCtD
Zaleplon—Malaise—Epirubicin—uterine cancer	0.000158	0.000415	CcSEcCtD
Zaleplon—Nervousness—Doxorubicin—uterine cancer	0.000157	0.000413	CcSEcCtD
Zaleplon—Vertigo—Epirubicin—uterine cancer	0.000157	0.000413	CcSEcCtD
Zaleplon—Syncope—Epirubicin—uterine cancer	0.000157	0.000413	CcSEcCtD
Zaleplon—Back pain—Doxorubicin—uterine cancer	0.000157	0.000412	CcSEcCtD
Zaleplon—Palpitations—Epirubicin—uterine cancer	0.000155	0.000407	CcSEcCtD
Zaleplon—Loss of consciousness—Epirubicin—uterine cancer	0.000154	0.000404	CcSEcCtD
Zaleplon—Nausea—Etoposide—uterine cancer	0.000151	0.000398	CcSEcCtD
Zaleplon—Hypertension—Epirubicin—uterine cancer	0.000151	0.000397	CcSEcCtD
Zaleplon—Ill-defined disorder—Doxorubicin—uterine cancer	0.00015	0.000395	CcSEcCtD
Zaleplon—Anaemia—Doxorubicin—uterine cancer	0.00015	0.000393	CcSEcCtD
Zaleplon—Chest pain—Epirubicin—uterine cancer	0.000149	0.000392	CcSEcCtD
Zaleplon—Arthralgia—Epirubicin—uterine cancer	0.000149	0.000392	CcSEcCtD
Zaleplon—Myalgia—Epirubicin—uterine cancer	0.000149	0.000392	CcSEcCtD
Zaleplon—Agitation—Doxorubicin—uterine cancer	0.000149	0.000391	CcSEcCtD
Zaleplon—Anxiety—Epirubicin—uterine cancer	0.000149	0.00039	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000148	0.000389	CcSEcCtD
Zaleplon—Discomfort—Epirubicin—uterine cancer	0.000147	0.000387	CcSEcCtD
Zaleplon—Malaise—Doxorubicin—uterine cancer	0.000146	0.000384	CcSEcCtD
Zaleplon—Dry mouth—Epirubicin—uterine cancer	0.000146	0.000383	CcSEcCtD
Zaleplon—Vertigo—Doxorubicin—uterine cancer	0.000146	0.000382	CcSEcCtD
Zaleplon—Syncope—Doxorubicin—uterine cancer	0.000145	0.000382	CcSEcCtD
Zaleplon—Confusional state—Epirubicin—uterine cancer	0.000144	0.000379	CcSEcCtD
Zaleplon—Palpitations—Doxorubicin—uterine cancer	0.000143	0.000376	CcSEcCtD
Zaleplon—Anaphylactic shock—Epirubicin—uterine cancer	0.000143	0.000376	CcSEcCtD
Zaleplon—Oedema—Epirubicin—uterine cancer	0.000143	0.000376	CcSEcCtD
Zaleplon—Loss of consciousness—Doxorubicin—uterine cancer	0.000142	0.000374	CcSEcCtD
Zaleplon—Shock—Epirubicin—uterine cancer	0.000141	0.000369	CcSEcCtD
Zaleplon—Nervous system disorder—Epirubicin—uterine cancer	0.00014	0.000368	CcSEcCtD
Zaleplon—Hypertension—Doxorubicin—uterine cancer	0.00014	0.000368	CcSEcCtD
Zaleplon—Tachycardia—Epirubicin—uterine cancer	0.00014	0.000366	CcSEcCtD
Zaleplon—Skin disorder—Epirubicin—uterine cancer	0.000139	0.000365	CcSEcCtD
Zaleplon—Hyperhidrosis—Epirubicin—uterine cancer	0.000138	0.000363	CcSEcCtD
Zaleplon—Chest pain—Doxorubicin—uterine cancer	0.000138	0.000362	CcSEcCtD
Zaleplon—Arthralgia—Doxorubicin—uterine cancer	0.000138	0.000362	CcSEcCtD
Zaleplon—Myalgia—Doxorubicin—uterine cancer	0.000138	0.000362	CcSEcCtD
Zaleplon—Anxiety—Doxorubicin—uterine cancer	0.000138	0.000361	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000137	0.00036	CcSEcCtD
Zaleplon—Discomfort—Doxorubicin—uterine cancer	0.000136	0.000358	CcSEcCtD
Zaleplon—Anorexia—Epirubicin—uterine cancer	0.000136	0.000358	CcSEcCtD
Zaleplon—Dry mouth—Doxorubicin—uterine cancer	0.000135	0.000354	CcSEcCtD
Zaleplon—Hypotension—Epirubicin—uterine cancer	0.000134	0.000351	CcSEcCtD
Zaleplon—Confusional state—Doxorubicin—uterine cancer	0.000133	0.00035	CcSEcCtD
Zaleplon—Anaphylactic shock—Doxorubicin—uterine cancer	0.000132	0.000347	CcSEcCtD
Zaleplon—Oedema—Doxorubicin—uterine cancer	0.000132	0.000347	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00013	0.000342	CcSEcCtD
Zaleplon—Shock—Doxorubicin—uterine cancer	0.00013	0.000342	CcSEcCtD
Zaleplon—Nervous system disorder—Doxorubicin—uterine cancer	0.00013	0.000341	CcSEcCtD
Zaleplon—Insomnia—Epirubicin—uterine cancer	0.000129	0.00034	CcSEcCtD
Zaleplon—Tachycardia—Doxorubicin—uterine cancer	0.000129	0.000339	CcSEcCtD
Zaleplon—Skin disorder—Doxorubicin—uterine cancer	0.000128	0.000337	CcSEcCtD
Zaleplon—Paraesthesia—Epirubicin—uterine cancer	0.000128	0.000337	CcSEcCtD
Zaleplon—Hyperhidrosis—Doxorubicin—uterine cancer	0.000128	0.000336	CcSEcCtD
Zaleplon—Dyspnoea—Epirubicin—uterine cancer	0.000127	0.000335	CcSEcCtD
Zaleplon—Somnolence—Epirubicin—uterine cancer	0.000127	0.000334	CcSEcCtD
Zaleplon—Anorexia—Doxorubicin—uterine cancer	0.000126	0.000331	CcSEcCtD
Zaleplon—Dyspepsia—Epirubicin—uterine cancer	0.000126	0.000331	CcSEcCtD
Zaleplon—Decreased appetite—Epirubicin—uterine cancer	0.000124	0.000326	CcSEcCtD
Zaleplon—Hypotension—Doxorubicin—uterine cancer	0.000124	0.000325	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000123	0.000324	CcSEcCtD
Zaleplon—Constipation—Epirubicin—uterine cancer	0.000122	0.000321	CcSEcCtD
Zaleplon—Pain—Epirubicin—uterine cancer	0.000122	0.000321	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000121	0.000317	CcSEcCtD
Zaleplon—Insomnia—Doxorubicin—uterine cancer	0.00012	0.000314	CcSEcCtD
Zaleplon—Paraesthesia—Doxorubicin—uterine cancer	0.000119	0.000312	CcSEcCtD
Zaleplon—Dyspnoea—Doxorubicin—uterine cancer	0.000118	0.00031	CcSEcCtD
Zaleplon—Feeling abnormal—Epirubicin—uterine cancer	0.000118	0.000309	CcSEcCtD
Zaleplon—Somnolence—Doxorubicin—uterine cancer	0.000118	0.000309	CcSEcCtD
Zaleplon—Gastrointestinal pain—Epirubicin—uterine cancer	0.000117	0.000307	CcSEcCtD
Zaleplon—Dyspepsia—Doxorubicin—uterine cancer	0.000116	0.000306	CcSEcCtD
Zaleplon—Decreased appetite—Doxorubicin—uterine cancer	0.000115	0.000302	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000114	0.0003	CcSEcCtD
Zaleplon—Urticaria—Epirubicin—uterine cancer	0.000114	0.000298	CcSEcCtD
Zaleplon—Pain—Doxorubicin—uterine cancer	0.000113	0.000297	CcSEcCtD
Zaleplon—Constipation—Doxorubicin—uterine cancer	0.000113	0.000297	CcSEcCtD
Zaleplon—Abdominal pain—Epirubicin—uterine cancer	0.000113	0.000297	CcSEcCtD
Zaleplon—Body temperature increased—Epirubicin—uterine cancer	0.000113	0.000297	CcSEcCtD
Zaleplon—Feeling abnormal—Doxorubicin—uterine cancer	0.000109	0.000286	CcSEcCtD
Zaleplon—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000108	0.000284	CcSEcCtD
Zaleplon—Urticaria—Doxorubicin—uterine cancer	0.000105	0.000276	CcSEcCtD
Zaleplon—Abdominal pain—Doxorubicin—uterine cancer	0.000105	0.000275	CcSEcCtD
Zaleplon—Body temperature increased—Doxorubicin—uterine cancer	0.000105	0.000275	CcSEcCtD
Zaleplon—Asthenia—Epirubicin—uterine cancer	0.000103	0.000269	CcSEcCtD
Zaleplon—Pruritus—Epirubicin—uterine cancer	0.000101	0.000266	CcSEcCtD
Zaleplon—Asthenia—Doxorubicin—uterine cancer	9.49e-05	0.000249	CcSEcCtD
Zaleplon—Dizziness—Epirubicin—uterine cancer	9.45e-05	0.000248	CcSEcCtD
Zaleplon—Pruritus—Doxorubicin—uterine cancer	9.36e-05	0.000246	CcSEcCtD
Zaleplon—Rash—Epirubicin—uterine cancer	9.01e-05	0.000237	CcSEcCtD
Zaleplon—Dermatitis—Epirubicin—uterine cancer	9.01e-05	0.000237	CcSEcCtD
Zaleplon—Headache—Epirubicin—uterine cancer	8.96e-05	0.000235	CcSEcCtD
Zaleplon—Dizziness—Doxorubicin—uterine cancer	8.75e-05	0.00023	CcSEcCtD
Zaleplon—Nausea—Epirubicin—uterine cancer	8.49e-05	0.000223	CcSEcCtD
Zaleplon—Rash—Doxorubicin—uterine cancer	8.34e-05	0.000219	CcSEcCtD
Zaleplon—Dermatitis—Doxorubicin—uterine cancer	8.33e-05	0.000219	CcSEcCtD
Zaleplon—Headache—Doxorubicin—uterine cancer	8.29e-05	0.000218	CcSEcCtD
Zaleplon—Nausea—Doxorubicin—uterine cancer	7.86e-05	0.000206	CcSEcCtD
